Status:
UNKNOWN
Rheumatoid Arthritis Hematological Indices
Lead Sponsor:
Assiut University
Conditions:
Rheumatoid Arthritis
Serum Albumin Low
Eligibility:
All Genders
Brief Summary
Rheumatoid arthritis is a chronic systemic inflammatory and autoimmune disease, characterized by disordered immunity, not regulated cytokines and inflammatory infiltration of the synovial joints. It i...
Detailed Description
The etiology of Rheumatoid arthritis is complex, it is established that the gene environmental interaction plays critical roles in the pathology of Rheumatoid arthritis, in addition to smoking, lifest...
Eligibility Criteria
Inclusion
- Adult RA Patients who fulfilled the 2010 European league against rheumatism criteria for the classification of RA
Exclusion
- Individuals with concomitant other autoimmune diseases 2. RA patients with anemia, pregnancy, postpartum, diabetes, obesity hypertension.
- 3\. Patients with age less than 18 years 4. Patients with end stage organ failure.
- 5\. Patients with liver diseases.
- 6\. Patients with hematological disorders.
- 7\. Patients with malignancies
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04416997
Start Date
March 1 2020
End Date
January 30 2023
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine
Asyut, Egypt, 71515